Abbott posts Q4 sales below expectations [Yahoo! Finance]
Exact Sciences Corporation (EXAS)
Last exact sciences corporation earnings: 2/11 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.exactsciences.com/investor-relations/default.aspx
Company Research
Source: Yahoo! Finance
By the numbers Q4 sales: $11.46 billion 4.4% increase year over year 2025 sales: $44.3 billion 5.7% increase year over year Abbott's fourth quarter sales came in below expectations, as the company navigated challenges in its nutrition and diagnostics businesses. Abbott also reported less growth than expected in its medical devices segment. The company's revenue of $11.46 billion for the quarter fell short of analysts' consensus of $11.8 billion, Leerink Partners analyst Mike Kratky wrote in a research note on Thursday. Abbott's shares opened at $107.53 on Thursday, down nearly 11% from Wednesday's closing price. RBC Capital Markets analyst Shagun Singh wrote to clients that sales in Abbott's nutrition, diagnostics and medical devices business all were below expectations, with the biggest shortfall in nutrition. Abbott CEO Robert Ford told investors the nutrition segment has been dealing with surges in costs following the COVID-19 pandemic, and higher prices had suppre
Show less
Read more
Impact Snapshot
Event Time:
EXAS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EXAS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EXAS alerts
High impacting Exact Sciences Corporation news events
Weekly update
A roundup of the hottest topics
EXAS
News
- Exact Sciences Corp. (EXAS) Rose Following the Acquisition Announcement [Yahoo! Finance]Yahoo! Finance
- Alger Small Cap Growth Fund Q4 2025 Portfolio Update [Seeking Alpha]Seeking Alpha
- A Look At Exact Sciences (EXAS) Valuation After Its Strong Recent Share Price Momentum [Yahoo! Finance]Yahoo! Finance
- Halper Sadeh LLC Encourages PEN, EXAS, DBRG, FFIC Shareholders to Contact the Firm to Discuss Their RightsGlobeNewswire
- $HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--PEN, DBRG, FFIC, and EXASPR Newswire
EXAS
Earnings
- 11/3/25 - Beat
EXAS
Sec Filings
- 1/30/26 - Form DEFA14A
- 1/23/26 - Form DEFA14A
- 1/9/26 - Form DEFM14A
- EXAS's page on the SEC website